BIOPOL Share Price | Biopol Chemicals Ltd Stock Analysis & Recommendation

Q: Why is Biopol Chemicals Ltd falling/rising?

As of 10-Jun, Biopol Chemicals Ltd's stock price is falling, currently at 94.60, reflecting a change of -5.6, or -5.59%. This decline is evident in the stock's performance over various periods, with a significant drop of -10.84% over the past week and -15.61% over the past month, both of which are considerably worse than the benchmark Sensex, which has only decreased by -0.81% and -3.98% respectively during the same time frames.Additionally, the stock is underperforming its sector by -4.01% today and is trading lower than its moving averages across all time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Although there has been a notable increase in investor participation, with delivery volume rising by 210.98% against the 5-day average, this has not translated into a positive price movement. The liquidity of the stock remains adequate for trading, but the overall negative performance metrics indicate that the stock is currently in a downward trend.

Q: What does Biopol Chemicals do?

Overview:Biopol Chemicals Ltd operates in the specialty chemicals industry and is categorized as a micro-cap company.History:There are no specific details available regarding the incorporation year or any status changes. Additionally, there is no sales or profit data reported for the latest quarter.Financial Snapshot:Most recent Net Sales: N/AMost recent Net Profit: N/AMarket-cap value: INR 111 Cr (Micro Cap)Key Metrics:P/E: 11.00Industry P/E: 42Dividend Yield: 0.00%Debt-Equity: 0.16Return on Equity: 17.97%Price-to-Book: 2.24Contact Details:Registrar Address: Not available.

Technical Trend Update: Biopol Chemicals witnessed a change in Technical Grade on 09 Jun 2026. Click here to discover latest technical change!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

68.4 k (21.28%) Volume

Shareholding (Mar 2026)

FII

9.30%

Held by 3 FIIs

DII

2.92%

Held by 0 DIIs

Promoter

65.81%

Why is Biopol Chemicals Ltd falling/rising?

11-Jun-2026

As of 10-Jun, Biopol Chemicals Ltd's stock price is declining at 94.60, down -5.59%, with significant drops over the past week and month, underperforming its sector and moving averages. Despite increased investor participation, the stock remains in a downward trend with negative performance metrics.

View full answer

What does Biopol Chemicals do?

11-Jun-2026

Biopol Chemicals Ltd is a micro-cap company in the specialty chemicals industry, with a market cap of INR 111 Cr. It has a P/E ratio of 11.00, a debt-equity ratio of 0.16, and no reported net sales or profit for the latest quarter.

View full answer

Which are the latest news on Biopol Chemicals?

10-Jun-2026

No latest news for Biopol Chemicals found.

Compare Biopol Chemicals with Similar Stocks

Polson Ambani Orgochem Chemcrux Enterp.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Specialty Chemicals

Market cap

INR 111 Cr (Micro Cap)

P/E

11.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.16

Return on Equity

17.97%

Price to Book

2.24

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-5.26%

6 Months

0.0%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Biopol Chemicals for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

5.66

Debt to EBITDA (avg)

0.63

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

1.39

Tax Ratio

25.54%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

12.22%

ROCE (avg)

23.06%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.01

EV to EBIT

8.12

EV to EBITDA

8.06

EV to Capital Employed

1.87

EV to Sales

1.34

PEG Ratio

Dividend Yield

ROCE (Latest)

23.07%

ROE (Latest)

17.97%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

No Signal

Bollinger Bands

KST

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 3 FIIs (9.3%)

Promoter with highest holding

Santanu Sarkar (64.14%)

Highest Public shareholder

Kingsman Wealth Management Privatenlimited (5.55%)

Individual Investors Holdings

7.67%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Biopol Chemicals"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Biopol Chemicals"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Biopol Chemicals"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 64.85% vs 182.39% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 108.12% vs 236.72% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "81.14",
          "val2": "49.22",
          "chgp": "64.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.45",
          "val2": "6.47",
          "chgp": "107.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.52",
          "val2": "0.60",
          "chgp": "153.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.97",
          "val2": "4.31",
          "chgp": "108.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.58%",
          "val2": "13.15%",
          "chgp": "3.43%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]